The Delhi High Court on Monday deferred its hearing on a petition challenging an advisory issued by the Indian Council of Medical Research (ICMR), barring repetition of RT-PCR tests on individuals who tested positive for Covid-19.
The Delhi High Court's directions to National Centre for Disease Control came after it was informed by Amicus Curiae Rajshekhar Rao that there is a need to study the effectiveness of several medications prescribed and administered by the practicing doctor.
The Delhi High Court on Tuesday dismissed a writ petition seeking modification of Covid-19 treatment protocol for mild cases with a cost of Rs 25,000, saying the petition though filed as a Public Interest Litigation is nothing but Publicity Interest Litigation.
While the manufacturer of Covaxin got itself in a jam with Brazil following an inspection of its Hyderabad facility, AstraZeneca’s vaccine was put on hold in several nations after reports of blood clots. How safe are these vaccines?